Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134097) titled 'Research on the application of artificial intelligence-driven multimodal ultrasound imaging in the precise evaluation of pancreatic tumors' on Oct. 10.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Peking Union Medical College Hospital
Condition:
pancreatic cancer
Intervention:
Gold Standard:Clear clinical and pathological diagnoses
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-11-01
Target Sample Size: Target condition:300;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/s...